ITM2A

Across TCGA pan-cancer cohorts, ITM2A mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ITM2A’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where ITM2A mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ITM2A is over-expressed in tumor, although a few such as LSCC show the opposite, repressed pattern.

LSCC and CCRCC are the cancer types where ITM2A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ITM2A mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	All	All	−0.436	<.001	4	view →
CCRCC	Male	All	+0.381	.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

ITM2A–LSCC

Open the LSCC breakdown →